Photo taken from Tom Powles/Twitter
Dec 4, 2023, 15:11
Tom Powles: This is the next chapter IMO
Tom Powles, Director of Barts Cancer Centre, shared a post on X/Twitter:
“Treatment for muscle invasive bladder cancer will change if the ongoing R3s are +ve. Neoadjuvant IO/ADC combination, bladder sparing approaches, intravesical therapy (TAR200) & ctDNA will improve outcomes and spare patients unnecessary treatments. This is the next chapter IMO.”
Source: Tom Powles/Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 21, 2025, 16:16
Jan 21, 2025, 16:13
Jan 21, 2025, 16:10
Jan 21, 2025, 16:04
Jan 21, 2025, 15:59
Jan 21, 2025, 15:59
Jan 21, 2025, 15:31
Jan 21, 2025, 15:31